Table 1.
Baseline characteristics of enrolled patients
| Overall (N = 85) | Hydroxychloroquine (n = 42) | Azithromycin (n = 43) | |
|---|---|---|---|
| Age, yr | 55 (42–65) | 51 (42–60) | 58 (43–68) |
| Sex, F, n (%) | 33 (39) | 19 (44) | 14 (33) |
| Latinx ethnicity, n (%) | 32 (38) | 17 (40) | 15 (36) |
| Race, n (%) | |
||
| Black/African American | 1 (1) | 1 (2) | 0 (0) |
| Native Hawaiian/Pacific Islander | 10 (12) | 6 (14) | 4 (10) |
| American Indian/Alaska Native | 8 (9) | 3 (7) | 5 (12) |
| White | 54 (64) | 26 (60) | 28 (67) |
| Nonwhite race or Latinx ethnicity | 52 (61) | 29 (67) | 23 (55) |
| Other/multiple | 12 (14) | 7 (16) | 5 (12) |
| Admission SOFA score, median (IQR) | 3 (2–4) | 3 (2–3) | 3 (2–4) |
| Comorbidities | |||
| Total Charlson count, median (IQR) | 1 (0–2) | 1 (0–2) | 0 (0–2) |
| No comorbidities, n (%) | 41 (48) | 18 (42) | 23 (55) |
| Baseline ordinal scale, n (%) | |||
| 3 (hospitalized no oxygen) | 12 (14) | 6 (14) | 6 (14) |
| 4 (hospitalized, some oxygen) | 47 (55) | 24 (56) | 23 (55) |
| 5 (HFNC or NIV) | 13 (15) | 7 (16) | 6 (14) |
| 6 (mechanical ventilation) | 9 (11) | 4 (9) | 5 (12) |
| 7 (mechanical ventilation and other organ support) | 4 (5) | 2 (5) | 2 (5) |
| Duration of symptoms (d), median (IQR) | 8 (6–12) | 9 (7–11) | 8 (5–12) |
Definition of abbreviations: HFNC = high-flow nasal cannula oxygen; IQR = interquartile range; NIV = noninvasive ventilation; SOFA = Sequential Organ Failure Assessment.